Marcio Machado

Summary

Affiliation: University of Toronto
Country: Canada

Publications

  1. ncbi request reprint International drug price comparisons: quality assessment
    Marcio Machado
    Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada
    Rev Panam Salud Publica 29:46-51. 2011
  2. doi request reprint Comparison of SSRIs and SNRIs in major depressive disorder: a meta-analysis of head-to-head randomized clinical trials
    M Machado
    Toronto Health Economics and Technology Assessment Collaborative THETA, University of Toronto, Toronto, ON, Canada
    J Clin Pharm Ther 35:177-88. 2010
  3. ncbi request reprint Pharmacoeconomics of antidepressants in moderate-to-severe depressive disorder in Colombia
    Marcio Machado
    Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada
    Rev Panam Salud Publica 24:233-9. 2008
  4. doi request reprint Efficacy of clodronate, pamidronate, and zoledronate in reducing morbidity and mortality in cancer patients with bone metastasis: a meta-analysis of randomized clinical trials
    Marcio Machado
    Toronto Health Economics and Technology Assessment Collaborative THETA, University of Toronto, Toronto, Ontario, Canada
    Clin Ther 31:962-79. 2009
  5. doi request reprint Cost-effectiveness of specialized multidisciplinary heart failure clinics in Ontario, Canada
    Harindra C Wijeysundera
    Division of Cardiology, Schulich Heart Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada
    Value Health 13:915-21. 2010
  6. doi request reprint Advanced cutaneous malignant melanoma: a systematic review of economic and quality-of-life studies
    Richard P Cashin
    Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON, Canada
    Value Health 11:259-71. 2008
  7. doi request reprint Systematic review and quality assessment of economic evaluations and quality-of-life studies related to generalized anxiety disorder
    Basil G Bereza
    Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Canada basil berezawutoronto
    Clin Ther 31:1279-308. 2009
  8. ncbi request reprint Screening for glaucoma in Canada: a systematic review of the literature
    Thomas R Einarson
    PharmIdeas Research and Consulting Inc, ON, Canada
    Can J Ophthalmol 41:709-21. 2006
  9. ncbi request reprint Evidence-based review of clinical outcomes of guideline-recommended pharmacotherapies for generalized anxiety disorder
    Basil G Bereza
    Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario
    Can J Psychiatry 57:470-8. 2012
  10. doi request reprint Sensitivity of patient outcomes to pharmacist interventions. Part III: systematic review and meta-analysis in hyperlipidemia management
    Marcio Machado
    Toronto Health Economics and Technology Assessment Collaborative, University of Toronto, Toronto, Ontario, Canada
    Ann Pharmacother 42:1195-207. 2008

Collaborators

Detail Information

Publications20

  1. ncbi request reprint International drug price comparisons: quality assessment
    Marcio Machado
    Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada
    Rev Panam Salud Publica 29:46-51. 2011
    ..To quantitatively summarize results (i.e., prices and affordability) reported from international drug price comparison studies and assess their methodological quality...
  2. doi request reprint Comparison of SSRIs and SNRIs in major depressive disorder: a meta-analysis of head-to-head randomized clinical trials
    M Machado
    Toronto Health Economics and Technology Assessment Collaborative THETA, University of Toronto, Toronto, ON, Canada
    J Clin Pharm Ther 35:177-88. 2010
    ..Controversy exists whether serotonin-norepinephrine reuptake inhibitors (SNRIs) have improved efficacy compared with selective serotonin reuptake inhibitors (SSRIs)...
  3. ncbi request reprint Pharmacoeconomics of antidepressants in moderate-to-severe depressive disorder in Colombia
    Marcio Machado
    Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada
    Rev Panam Salud Publica 24:233-9. 2008
    ..To compare three antidepressant drugs from different classes used in treating moderate-to-severe major depressive disorder (MDD) in Colombian adults...
  4. doi request reprint Efficacy of clodronate, pamidronate, and zoledronate in reducing morbidity and mortality in cancer patients with bone metastasis: a meta-analysis of randomized clinical trials
    Marcio Machado
    Toronto Health Economics and Technology Assessment Collaborative THETA, University of Toronto, Toronto, Ontario, Canada
    Clin Ther 31:962-79. 2009
    ..Complications from skeletal-related events (SREs) constitute a challenge in the care of patients with metastatic bone disease (MBD) that originated from any type of malignancy...
  5. doi request reprint Cost-effectiveness of specialized multidisciplinary heart failure clinics in Ontario, Canada
    Harindra C Wijeysundera
    Division of Cardiology, Schulich Heart Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada
    Value Health 13:915-21. 2010
    ..Specialized multidisciplinary clinics have been shown to reduce mortality in heart failure (HF). Our objective was to evaluate the cost-effectiveness of this model of care delivery...
  6. doi request reprint Advanced cutaneous malignant melanoma: a systematic review of economic and quality-of-life studies
    Richard P Cashin
    Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON, Canada
    Value Health 11:259-71. 2008
    ..We systematically reviewed published articles describing the impact of interventions (drugs and screening) on quality of life (QoL) in patients with MM, and articles that measured QoL in MM...
  7. doi request reprint Systematic review and quality assessment of economic evaluations and quality-of-life studies related to generalized anxiety disorder
    Basil G Bereza
    Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Canada basil berezawutoronto
    Clin Ther 31:1279-308. 2009
    ..The objectives of this article were to systematically review, summarize the results of, and assess the quality of economic evaluations and humanistic studies related to patients with generalized anxiety disorder (GAD)...
  8. ncbi request reprint Screening for glaucoma in Canada: a systematic review of the literature
    Thomas R Einarson
    PharmIdeas Research and Consulting Inc, ON, Canada
    Can J Ophthalmol 41:709-21. 2006
    ..To provide a recommendation on screening for glaucoma in Canada based on a review of recent evidence available in the literature...
  9. ncbi request reprint Evidence-based review of clinical outcomes of guideline-recommended pharmacotherapies for generalized anxiety disorder
    Basil G Bereza
    Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario
    Can J Psychiatry 57:470-8. 2012
    ..To quantify the rates of clinical outcomes of Canadian Psychiatric Association (CPA) guideline-recommended pharmacotherapies for generalized anxiety disorder (GAD) by drug classification within each treatment line...
  10. doi request reprint Sensitivity of patient outcomes to pharmacist interventions. Part III: systematic review and meta-analysis in hyperlipidemia management
    Marcio Machado
    Toronto Health Economics and Technology Assessment Collaborative, University of Toronto, Toronto, Ontario, Canada
    Ann Pharmacother 42:1195-207. 2008
    ..Multidisciplinary interventions, including those performed by pharmacists, are important for improving patients' outcomes...
  11. doi request reprint Assessing the reporting and scientific quality of meta-analyses of randomized controlled trials of treatments for anxiety disorders
    Basil G Bereza
    Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada
    Ann Pharmacother 42:1402-9. 2008
    ..Meta-analyses of randomized controlled trials (RCTs) constitute the highest level of evidence, but their usefulness depends on their quality...
  12. pmc Pain due to multiple sclerosis: analysis of the prevalence and economic burden in Canada
    Charles Piwko
    PharmIdeas Research and Consulting Inc, Oakville, Ontario, Canada
    Pain Res Manag 12:259-65. 2007
    ..Multiple sclerosis (MS) is a neurological disease affecting approximately 50,000 Canadians. Although studies have described overall MS costs, none have focused specifically on MS-related pain...
  13. doi request reprint Association of temporal trends in risk factors and treatment uptake with coronary heart disease mortality, 1994-2005
    Harindra C Wijeysundera
    Division of Cardiology, Schulich Heart Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
    JAMA 303:1841-7. 2010
    ..Coronary heart disease (CHD) mortality has declined substantially in Canada since 1994...
  14. doi request reprint Systematic review and meta-analysis of the effect of warming local anesthetics on injection pain
    Mary Ellen Hogan
    Graduate Department of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada
    Ann Emerg Med 58:86-98.e1. 2011
    ..We determine the effectiveness of warming local anesthetics to reduce pain in adults and children undergoing local anesthetic infiltration into intradermal or subcutaneous tissue...
  15. doi request reprint Efficacy of botulinum toxin type A for the prophylaxis of episodic migraine headaches: a meta-analysis of randomized, double-blind, placebo-controlled trials
    Adam J Shuhendler
    Department of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy, University of Toronto, Ontario, Canada
    Pharmacotherapy 29:784-91. 2009
    ..To assess the efficacy of botulinum toxin type A in lowering the frequency of migraine headaches in patients with episodic migraines...
  16. doi request reprint Blood glucose and subsequent cardiovascular disease: update of a meta-analysis
    Thomas R Einarson
    University of Toronto, ON, Canada
    Curr Med Res Opin 27:2155-63. 2011
    ..No restrictions were placed on language or publication date...
  17. doi request reprint Preventing pressure ulcers in long-term care: a cost-effectiveness analysis
    Ba Pham
    TorontoHealth Economics and Technology Assessment Collaborative, Department of Health Policy Management andEvaluation, University of Toronto, 144 College Street, Toronto, Ontario, Canada
    Arch Intern Med 171:1839-47. 2011
    ..Pressure ulcers are common in many care settings, with adverse health outcomes and high treatment costs. We evaluated the cost-effectiveness of evidence-based strategies to improve current prevention practice in long-term care facilities...
  18. ncbi request reprint Treatments for metastatic melanoma: synthesis of evidence from randomized trials
    Philip Lui
    Leslie Dan Faculty of Pharmacy, 144 College Street, Toronto, ON, Canada M5S 3M2
    Cancer Treat Rev 33:665-80. 2007
    ..Advanced melanomas (non-resectable Stage-III/IV) are fatal, with few effective treatments. It remains unclear if other drugs offer improvements over the standard, dacarbazine...
  19. ncbi request reprint Sensitivity of patient outcomes to pharmacist interventions. Part II: Systematic review and meta-analysis in hypertension management
    Marcio Machado
    Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada
    Ann Pharmacother 41:1770-81. 2007
    ..Hypertension is a major health concern worldwide due to its deleterious impact. Few studies have quantitatively assessed pharmacists' interventions in hypertensive patients...
  20. ncbi request reprint Probiotic safety in pregnancy: a systematic review and meta-analysis of randomized controlled trials of Lactobacillus, Bifidobacterium, and Saccharomyces spp
    Jean Jaques Dugoua
    Graduate Department of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy, University of Toronto, and Motherisk Program, Hospital for Sick Children, Toronto ON
    J Obstet Gynaecol Can 31:542-52. 2009
    ..No RCTs were available for Saccharomyces during pregnancy. Lactobacillus and Bifidobacterium had no effect on the incidence of Caesarean section, birth weight, or gestational age. The safety of Saccharomyces during pregnancy is unknown...